This delivery system introduced taxol to the brain via endocytosis of the interleukin-13 receptor subunit alpha-2 (IL-13RA2), which showed elevated expression in gliomas (Patent application: CN103655517 A). Here, IL13RA2 is linked to central nervous system cancer.